Table 3.
Baseline patient characteristics for chest wall planning patients
| Age | Pathology | TNM Stage | Clinical/pathologic Stage | ER | PR | HER2 | No. of positive LNs | Location of tumor | Size | Surgery | Reconstruction | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 40 | ILC | pT3 N1a M0 | pIIIa | + | + | - | 2/4 | Left | 7.0 cm | Left total mastectomy | Immediate implant-based |
| B | 59 | IDC | pT2 N0 Mx | pII | + | - | - | 0/15 | Left | 4.5 cm | Left modified radical mastectomy | None |
| C | 79 | mixed IDC/ILC | pT2 N2a M0 | pIIIa | + | + | - | 5/11 | Bilateral | 3.1 cm multifocal | Bilateral skin sparing mastectomy with left axillary dissection and right sentinel LN | Delayed immediate reconstruction with bilateral tissue expander placement |
| D | 41 | IDC | T1 N1 M0, ypT0N0M0 | cIIa | + | + | - | 0/16 | Left | no residual invasive carcinoma | Left modified radical mastectomy and right prophylactic mastectomy with sentinel lymph node | None |
| E | 59 | IDC | pT2N1a | pIIa | + | + | - | 1/1 | Left | 4.0 cm | Left simple mastectomy with sentinel LN | Immediate implant-based |
Abbreviations: ER = estrogen receptor; HER2 = human epidermal growth factor receptor 2; IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma; LN = lymph node; PR = progesterone receptor.